Combination treatment with mirabegron and solifenacin in patients with overactive bladder (OAB) - efficacy and safety results from a randomised phase II study (Symphony)

Abrams P1, Kelleher C2, Staskin D3, Kay R4, Martina R5, Newgreen D5, Paireddy A5, van Maanen R5, Ridder A5

Abstract Category

Detrusor Overactivity

Abstract 295
Pharmacology
Scientific Podium Poster Session 32
Friday 30th August 2013
16:50 - 16:55
116
Overactive Bladder Incontinence Clinical Trial
1. Bristol Urological Institute, Bristol, UK, 2. Guy's and St Thomas’ NHS Foundation Trust, London, UK, 3. Tufts U School of Medicine, Boston, MA, USA, 4. RK Statistics Ltd, Bakewell, UK, 5. Astellas Pharma BV, Leiden, the Netherlands
Presenter
D

David Staskin
Tufts U School of Medicine, Boston, MA, USA

Links

Abstract

10/03/2026 13:52:49